blaOXA-542介导鲍曼不动杆菌碳青霉烯耐药的特征研究
本研究对一株携带blaOXA-542的碳青霉烯耐药鲍曼不动杆菌进行分离鉴定,通过药敏试验、全基因组测序、基因敲低与表达载体构建等功能验证,发现blaOXA-542介导对碳青霉烯类和青霉素类耐药,对头孢菌素类无显著影响,并揭示其与Acinetobacter pitti的遗传环境密切相关,属于新ST2795Pas/ST3464Oxf谱系。
要点
- blaOXA-542介导鲍曼不动杆菌对碳青霉烯类和青霉素类耐药。
- 该基因对头孢菌素类耐药无显著影响。
- 菌株属于新谱系ST2795Pas/ST3464Oxf,需警惕传播。
核心结论
- blaOXA-542在鲍曼不动杆菌和大肠杆菌中介导碳青霉烯类和青霉素类耐药,对头孢菌素类无显著影响。
- 该研究报道了blaOXA-542介导的碳青霉烯和青霉素耐药在新ST2795Pas/ST3464Oxf谱系鲍曼不动杆菌中的出现。
研究设计与样本
- 研究对一株携带blaOXA-542的碳青霉烯耐药鲍曼不动杆菌进行分离和特征分析。
- 采用肉汤微量稀释法进行药敏试验,全基因组测序鉴定耐药与毒力决定簇。
- 通过基因敲低和表达载体构建进行耐药机制功能验证,采用细菌生长动力学试验评估β-内酰胺酶表达的适合度代价。
- 利用分子对接预测β-内酰胺酶与碳青霉烯类的潜在结合位点,通过比较基因组学和系统发育树分析遗传特征。
主要发现
- blaOXA-542使鲍曼不动杆菌和大肠杆菌对碳青霉烯类和青霉素类耐药,对头孢菌素类无显著影响。
- 改良碳青霉烯灭活试验(mCIM)进一步证实blaOXA-542水解美罗培南的能力。
- blaOXA-542在大肠杆菌BL21中表达未显示显著生长速率改变。
- blaOXA-542遗传环境比较分析显示其与Acinetobacter pitti密切相关。
临床怎么用
- 对碳青霉烯耐药鲍曼不动杆菌感染,应关注blaOXA-542等OXA型碳青霉烯酶基因的检测与鉴定。
- 该菌株对头孢菌素类无显著耐药影响,提示特定β-内酰胺类药物的敏感性可能保留,但需依据药敏结果选用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carbapenem-resistant Acinetobacter baumannii (CRAB) causes multiple anatomical site infections, representing a significant public health threat. AIM: This study reports the isolation and characterization of a carbapenem-resistant A. baumannii harbouring blaOXA-542, followed by a comprehensive investigation of its antimicrobial resistance mechanisms and genomic characteristics. METHODS: Firstly, antimicrobial susceptibility testing was performed using the broth microdilution method. Subsequently, whole-genome sequencing was employed to identify and characterize the resistance and virulence determinants. The functional validation of resistance mechanisms was performed by gene knockdown and construction of expression vectors. The fitness cost of β-lactamase expression was identified by a bacterial growth kinetic test. Molecular docking was utilized to predict potential binding sites of β-lactamase and carbapenems. Finally, the genetic characteristics of the isolates were analysed through comparative genomics analyses and phylogenetic tree construction. RESULTS AND CONCLUSIONS: The results demonstrated that blaOXA-542 confers resistance to carbapenem and penicillin in A. baumannii and Escherichia coli while exhibiting no significant impact on cephalosporins. The ability of blaOXA-542 to hydrolyze meropenem was further confirmed by modified carbapenem inactivation assay (mCIM). Expression of blaOXA-542 in E. coli BL21 showed no significant growth rate alteration. Comparative analysis of the blaOXA-542 genetic environment revealed a close association with Acinetobacter pitti. This study reports the emergence of blaOXA-542-mediated carbapenem and penicillin resistance in a novel A. baumannii lineage (ST2795Pas/ST3464Oxf), highlighting the urgent need for rational antibiotic use against specific pathogens.
引用
- Hao J, Lu F, Chen P, et al. Characterization of blaOXA-542-mediated carbapenem resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2025. PMID: 40879453. doi:10.1093/jac/dkaf311
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。